AzTrials
AzTrials

SARS-CoVDenutCOVIDNCT04503525

Nutritional Assessment of Hospitalized Patients With COVID-19

An observational study of SARS-CoV and Nutrition Disorders, run by Lille Catholic University at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The nutritional consequences of the infection by the SARS-CoV-2 are as follows: A severe respiratory infection induces an inflammatory syndrome and hypercatabolism, as well as an increase in energy expenditure related to ventilatory work; nutritional requirements (calories and protein) are therefore increased. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
SARS-CoV, Nutrition Disorders
What is being tested?
Nutritional assessment
How many people
90 participants
Where
1 siteFrance
Study dates
25 May 2020to 30 Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient with COVID 19 disease

Who may be able to join

  • Patient on conventional hospitalization (duration less than 72 hours)
  • Age > 18 years old
  • COVID 19 diagnosed by Real Time Polymerase Chain Reaction (RT-PCR)
  • Patient agreed to participate in the study
  • Patient affiliated to French social security

Who cannot join

  • Patient hospitalized in intensive care units during more than 72 hours

Trial locations and contacts

1 site in 1 country.

France1 site
  • Saint-Vincent Hospital

    Lille, Haut-de-France, 59000

Other trials in France

About this study

Official title: Nutritional Assessment of French Hospitalized Patients Infected With COVID-19

The nutritional consequences of the infection by the SARS-CoV-2 are as follows:

  • A severe respiratory infection induces an inflammatory syndrome and hypercatabolism, as well as an increase in energy expenditure related to ventilatory work; nutritional requirements (calories and protein) are therefore increased.
  • Food intake is often reduced by several factors: anorexia secondary to infection, respiratory discomfort, anosmia, ageusia, obesity, stress, confinement, organizational problems limiting meal assistance.

Then, it is important to asses the nutritional status of COVID patients hospitalized in conventional COVID units (excluding intensive care).

Being tested
Nutritional assessment
Keywords
COVID-19, Nutrition disorders
Medical subject headings
Severe Acute Respiratory Syndrome, Nutrition Disorders, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutritional assessmentOther

    Nutritional assessment in COVID patients

Study groups in NCT04503525
Study groupRoleWhat they receive
COVID 19 hospitalized patientsCOVID 19 infected patients admitted in conventional hospitalization for less than 72 hours
Receives: Other: Nutritional assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nutritional status of COVID infected patients

    The nutritional status of patients within the first 72 hours after hospital admission will be categorized according to the French Haute Authorité de Santé (France, 2019)

    • non-malnourished patient
    • moderately malnourished patient
    • severely malnourished patient

    Measured: Up to 72 hours

Secondary outcomes (2)
  1. Correlation between the nutritional status and the supplemental oxygen requirement

    The supplemental oxygen requirement classified as follows:

    • non-severe: no need of Oxygen
    • light: 1 - 2 l/min
    • moderate: 3 - 5 l/min
    • severe: > 5 l/min
    • critical: mechanical ventilation

    Measured: Up to 72 hours

  2. Correlation between the nutritional status and the prognostic after hospitalization

    The prognostic after hospitalization will be classified as follows:

    • Hospital discharge
    • Transfer to the intensive care unit
    • Transfer to other unit
    • Follow-up care and rehabilitation
    • Death

    Measured: Up to 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2020
  2. Study start25 May 2020
  3. Primary completion25 May 2021
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04503525
Sponsor's protocol ID
RC-P00100
Acronym
DenutCOVID
Status last verified
Jan 2022
First submitted
4 Aug 2020
Last updated
6 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of SARS-CoV and Nutrition Disorders, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nutritional status of COVID infected patients (time frame: Up to 72 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in